Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE:2196.HK
Sector
Location
Market Cap
USD 9.66 B
Share Price
USD 2.64
Avg Daily Volume
10,687,285
Change (1 day)
-0.60%
Change (1 year)
65.53%
Change (YTD)
45.30%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 613.17 M
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Operating Cash Flow is USD 613.17 M for the year ending December 31, 2024, a 27.51% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 480.89 M, a -21.32% change year over year.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 611.17 M, a -1.66% change year over year.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 621.45 M, a 57.24% change year over year.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 395.22 M, a -14.59% change year over year.
StockViz
Competitors
Fresenius SE & Co. KGaA
USD 55.21
FRE.DE
+0.28
0.51%
Terumo Corporation
USD 18.42
4543.T
-0.05
-0.25%
STERIS plc
USD 247.50
STE
-2.05
-0.82%
Labcorp Holdings Inc.
USD 276.56
LH
-1.54
-0.55%
Sino Biopharmaceutical Limited
USD 1.04
1177.HK
+0.05
5.42%
Baxter International Inc.
USD 23.85
BAX
-0.42
-1.73%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.37
4.62%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.28
300832.SZ
-0.02
-0.25%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.36
0874.HK
-0.04
-1.62%
Lepu Medical Technology (Beijing) Co., Ltd.
USD 2.52
300003.SZ
-0.04
-1.61%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.91
600079.SS
+0.02
0.64%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
USD 6.46
600329.SS
+0.02
0.38%
Inner Mongolia Furui Medical Science Co., Ltd.
USD 8.85
300049.SZ
-0.62
-6.56%
AddLife AB (publ)
USD 17.86
ALIF-B.ST
+0.06
0.33%
Zhejiang Jolly Pharmaceutical Co.,LTD
USD 2.74
300181.SZ
-0.01
-0.29%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 55.21
FRE.DE
+0.28
0.51%
Terumo Corporation
USD 18.42
4543.T
-0.05
-0.25%
STERIS plc
USD 247.50
STE
-2.05
-0.82%
Labcorp Holdings Inc.
USD 276.56
LH
-1.54
-0.55%
Sino Biopharmaceutical Limited
USD 1.04
1177.HK
+0.05
5.42%
Baxter International Inc.
USD 23.85
BAX
-0.42
-1.73%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.37
4.62%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.28
300832.SZ
-0.02
-0.25%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.36
0874.HK
-0.04
-1.62%
Lepu Medical Technology (Beijing) Co., Ltd.
USD 2.52
300003.SZ
-0.04
-1.61%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.91
600079.SS
+0.02
0.64%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
USD 6.46
600329.SS
+0.02
0.38%
Inner Mongolia Furui Medical Science Co., Ltd.
USD 8.85
300049.SZ
-0.62
-6.56%
AddLife AB (publ)
USD 17.86
ALIF-B.ST
+0.06
0.33%
Zhejiang Jolly Pharmaceutical Co.,LTD
USD 2.74
300181.SZ
-0.01
-0.29%